UBS Group Reiterates “$82.00” Price Target for Acadia Healthcare (NASDAQ:ACHC)

UBS Group set a $82.00 price target on Acadia Healthcare (NASDAQ:ACHCGet Rating) in a report published on Monday, Stock Target Advisor reports.

A number of other equities analysts have also commented on the company. Mizuho lifted their price objective on Acadia Healthcare from $64.00 to $69.00 in a research note on Wednesday, May 4th. BMO Capital Markets lifted their price objective on shares of Acadia Healthcare from $67.00 to $82.00 in a research note on Friday, May 6th. StockNews.com began coverage on shares of Acadia Healthcare in a report on Thursday, March 31st. They issued a hold rating on the stock. SVB Leerink boosted their target price on shares of Acadia Healthcare from $80.00 to $90.00 and gave the company an outperform rating in a research note on Friday, April 8th. Finally, Credit Suisse Group increased their price target on shares of Acadia Healthcare from $74.00 to $78.00 and gave the stock an outperform rating in a report on Wednesday, March 2nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of Hold and a consensus price target of $75.57.

ACHC stock opened at $68.50 on Monday. The firm has a market cap of $6.20 billion, a PE ratio of 25.75, a price-to-earnings-growth ratio of 1.74 and a beta of 1.28. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a fifty day moving average price of $69.56 and a 200 day moving average price of $63.07. Acadia Healthcare has a fifty-two week low of $50.07 and a fifty-two week high of $76.69.

Acadia Healthcare (NASDAQ:ACHCGet Rating) last issued its earnings results on Tuesday, May 3rd. The company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.04. Acadia Healthcare had a return on equity of 10.16% and a net margin of 10.16%. The business had revenue of $616.65 million for the quarter, compared to analyst estimates of $606.49 million. During the same quarter last year, the company earned $0.47 EPS. The business’s quarterly revenue was up 11.9% on a year-over-year basis. On average, equities analysts predict that Acadia Healthcare will post 3.09 EPS for the current year.

A number of hedge funds and other institutional investors have recently modified their holdings of ACHC. CWM LLC bought a new position in Acadia Healthcare in the fourth quarter worth approximately $33,000. Point72 Hong Kong Ltd bought a new stake in shares of Acadia Healthcare in the 1st quarter valued at about $38,000. Patriot Financial Group Insurance Agency LLC purchased a new position in Acadia Healthcare during the 4th quarter valued at about $47,000. Quent Capital LLC purchased a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $115,000. Finally, Tranquility Partners LLC purchased a new stake in shares of Acadia Healthcare in the 1st quarter worth approximately $209,000. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

Acadia Healthcare Company Profile (Get Rating)

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.

Featured Articles

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.